Today@Dal
» Go to news mainFocus groups on spatial scholarship @ Dalhousie
Spatial scholarship is focused on the exploration space and place as central aspects to the pursuit of discovery, analysis, and integration of information; it is a cross-cutting disciplinary theme at Dalhousie.
The results of a recent ºÚÁϳԹÏÍøsurvey, based on more than 140 responses, show that scholars from a broad spectrum of disciplinary interests engage in spatial scholarship, including atmospheric change and land use management, architecture, community design and urban planning, environmental health and epidemiology, ecological modeling, hydrology and watershed research, ocean ecology, history and studies of social media.
As a follow up to the survey we will be conducting focus group interviews with the ºÚÁϳԹÏÍøcommunity. The aim of these focus groups is two-fold. The first is to understand more clearly what kinds of spatial scholarship occur among disciplines and subject areas. The second is to explore how spatial scholarship can be better advanced and supported at ºÚÁϳԹÏÍø.
Focus group meetings will be held at the following dates, times and locations (campuses):
1. Thursday, November 27, 2014 @ 9:30am in Room 5001 of the Rowe Management Bldg (Studley)
2. Thursday, November 27, 2014 @ 5:00pm in Room HB2 of the Medjuck Architecture Bldg (Sexton)
3. Friday, November 28, 2014 @ 10:00am in the Dairy Building Board Room, 11 River Road at the Faculty of Agriculture (Truro)
Your input is important to guiding future initiatives in spatial scholarship at ºÚÁϳԹÏÍø. To register or for more information, please contact Dr. Camilo Ordonez (camilo.ordonez@dal.ca or 494-6864) or Dr. Daniel Rainham (daniel.rainham@dal.ca or 494-1286)
Recent News
- Upcoming privacy and access to information session
- Call for 2025 OER Development Grant applications
- The Social to re‑open January 15
- New surplus items added
- Christmas Day kudos to the grounds crew
- Payroll update ‑ January 2025
- Employment Equity Plan progress report
- Seeking participants for RSV vaccine trial